Insider trade

Officer exercised or converted 670 LH derivative securities

Traded Feb 6, 2026 · Filed Feb 10, 2026

LabcorpLH

670
Shares

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 6, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 10, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references an employee stock purchase plan

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000920148-26-000033

Filed / recorded

Feb 10, 2026, 8:18 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

LABCORP HOLDINGS INC.

Issuer CIK

920148

Ticker

LH

Reporting person

Brian J Caveney

Relationship

Officer

Officer title

EVP, Pres of ED, CMO & CSO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Feb 6, 2026

Transaction code

M

Shares / units

670

Acquired / disposed

Acquired (A)

Shares owned after

30,838.9234

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
Amount includes 57.1306 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan and 45.1355 shares acquired on December 31, 2025 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan.